Specialized Implantable Cellular and Biotherapeutic Agent Delivery Canisters for Niche Environments

Publication ID: 24-11857670_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Implantable Cellular and Biotherapeutic Agent Delivery Canisters for Niche Environments,” Published Technical Disclosure No. 24-11857670_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857670_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,670.

Summary of the Inventive Concept

A family of implantable canisters tailored for specific, high-stakes environments, such as disaster relief, high-security biocontainment, extreme weather conditions, high-altitude implantation, and underwater implantation.

Background and Problem Solved

The original implantable cellular and biotherapeutic agent delivery canister, while effective for general therapeutic applications, has limitations when applied to unique operational environments. The new inventive concept addresses these limitations by adapting the canister design to cater to specific niche markets, ensuring reliable and controlled delivery of therapeutically active agents in challenging situations.

Detailed Description of the Inventive Concept

The new inventive concept encompasses four specialized canister designs: (1) a disaster relief canister with enhanced biocompatibility and rapid agent diffusion; (2) a high-security biocontainment canister with advanced metallurgic materials and tamper-evident features; (3) an extreme weather condition canister with enhanced thermal resistance and shock-absorbing properties; (4) a high-altitude implantation canister with optimized internal pressure regulation; and (5) an underwater implantation canister with waterproof coatings and corrosion-resistant materials. Each design variation leverages the original canister's nanoscale through-porous structure and metallic material shell, while incorporating unique features to address the specific challenges of its target environment.

Novelty and Inventive Step

The new claims introduce novel adaptations of the original canister design to cater to specific, high-stakes environments. The inventive step lies in the application of the original canister's principles to these niche markets, resulting in a family of specialized canisters that address previously unmet needs.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include canisters designed for space exploration, high-radiation environments, or applications requiring advanced encryption and data storage. Variations could also involve the integration of sensors, microelectronics, or other technologies to enhance the canisters' functionality and adaptability.

Potential Commercial Applications and Market

The specialized implantable canisters have significant commercial potential in various industries, including disaster relief, biodefense, environmental monitoring, and aerospace. Target markets may include government agencies, research institutions, and private companies operating in these sectors.

CPC Classifications

SectionClassGroup
A A61 A61K9/0024
A A61 A61F2/022
A A61 A61K31/337
A A61 A61K31/397
A A61 A61K31/436
A A61 A61K31/65
A A61 A61K31/7036
A A61 A61K35/28
A A61 A61K38/14
A A61 A61K38/1866
A A61 A61K38/22
A A61 A61K39/395
A A61 A61K47/02
A A61 A61M39/0247
A A61 A61M2039/027
A A61 A61M2039/0261
A A61 A61M2039/0276
A A61 A61M2205/04

Field of Art

Biomedical device engineering, specifically implantable drug delivery systems and cellular encapsulation technologies, with expertise in nanoscale materials, metallic biocompatible structures, and controlled agent diffusion mechanisms

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or materials scientist with advanced degree, specialized knowledge in nanoporous metallic structures, experience in medical device design, understanding of controlled drug delivery principles, and familiarity with adapting medical technologies to specialized environmental conditions

Obviousness Rationale

A PHOSITA would recognize that the fundamental nanoscale through-porous structure and metallic shell from the source patent can be readily adapted to specialized environments by applying standard engineering modifications. The core technological principles of controlled agent diffusion and biocompatible encapsulation remain consistent across the disclosed variations. The PTD's adaptations represent predictable extensions of the original invention's core technological framework.

Obvious Combinations & Variations

Source Patent Element
Nanoscale through-porous structure with pore sizes between 20-5000 nm allowing metabolically active agent diffusion
PTD Variation
Specialized pore configurations for disaster relief, high-altitude, and underwater environments with modified diffusion characteristics
Obviousness Reasoning
A PHOSITA would recognize that pore size and configuration can be systematically adjusted to optimize agent diffusion in different environmental conditions using standard materials engineering techniques
Source Patent Element
Metallic shell material providing controlled secretion of metabolically active agents
PTD Variation
Introduction of environment-specific metallurgic compositions with enhanced thermal, corrosion, or pressure resistance
Obviousness Reasoning
Material selection and modification to enhance performance in specific environments represents a routine design optimization process for a skilled practitioner
Source Patent Element
Internal barrier for stabilizing metabolically active agents within the canister
PTD Variation
Specialized internal barriers designed for high-altitude pressure regulation or extreme temperature stability
Obviousness Reasoning
Adapting internal stabilization mechanisms to address environmental challenges is a predictable engineering solution using known material science principles
Source Patent Element
Biocompatible implantable device for cellular and biotherapeutic agent delivery
PTD Variation
Targeted canister designs for specific high-stakes environments like disaster relief and biocontainment
Obviousness Reasoning
Extending a medical device's core functionality to address niche market requirements represents a standard approach of technological adaptation and market segmentation
35 U.S.C. § 103 Summary: Based on US Patent 11857670's foundational teachings of a nanoporous metallic implantable canister for cellular and biotherapeutic agent delivery, the present disclosure demonstrates that the claimed variations represent obvious extensions readily apparent to a person having ordinary skill in the art. The systematic adaptation of the source patent's core technological principles to specialized environmental contexts would be considered a routine engineering design choice without requiring inventive insight.

Original Patent Information

Patent NumberUS 11,857,670
TitleImplantable cellular and biotherapeutic agent delivery canister
Assignee(s)NanoVault Medical LLC